Rebound effect after stopping beta-blockers.
D000319:Adrenergic beta-Antagonists; D006801:Humans; D011433:Propranolol; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D011433:Propranolol